0001415889-23-004313.txt : 20230306 0001415889-23-004313.hdr.sgml : 20230306 20230306163011 ACCESSION NUMBER: 0001415889-23-004313 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230302 FILED AS OF DATE: 20230306 DATE AS OF CHANGE: 20230306 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: O'Neill Gilmore Neil CENTRAL INDEX KEY: 0001742084 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37687 FILM NUMBER: 23709309 MAIL ADDRESS: STREET 1: 215 FIRST STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Editas Medicine, Inc. CENTRAL INDEX KEY: 0001650664 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 464097528 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11 HURLEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02141 BUSINESS PHONE: 617-401-9000 MAIL ADDRESS: STREET 1: 11 HURLEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02141 4 1 form4-03062023_040304.xml X0306 4 2023-03-02 0001650664 Editas Medicine, Inc. EDIT 0001742084 O'Neill Gilmore Neil C/O EDITAS MEDICINE, INC. 11 HURLEY ST. CAMBRIDGE MA 02141 true true false false CEO Common Stock 2023-03-02 4 A 0 50000 0 A 136655 D Stock Option (right to buy) 8.72 2023-03-02 4 A 0 150000 0 A 2033-03-01 Common Stock 150000 150000 D The common stock received by the Reporting Person was in connection with the grant of a restricted stock unit award to the Reporting Person, for no consideration, and which is scheduled to vest over four years with 25% of the units vesting on March 2, 2024 and the remaining 75% of the units scheduled to vest in equal quarterly installments thereafter through March 2, 2027. This option was granted on March 2, 2023 and is scheduled to vest over four years in equal monthly installments beginning on April 2, 2023 through March 2, 2027. /s/ Damien Grierson, Attorney-in-Fact 2023-03-06